Human NK Cell Mediated Toxicity Primer Library

Catalog No: HNKT-1 Supplier: RealTimePrimers Lot No: XXXXX Supplied as: solid Stability: store at -20°C

Description Contains 88 primer sets directed against NK cell mediated toxicity and 8 housekeeping primer sets. Provided in a 96-well microplate (20 ul - 10 uM). Perform up to 100 PCR arrays (based on 20 ul assay volume per reaction). Just add cDNA template and SYBR green master mix.

Gene List:

 BID BH3 interacting domain death agonist  IFNG interferon, gamma  CASP3 caspase 3, apoptosis-related cysteine  IFNGR1 interferon gamma 1 peptidase  IFNGR2 interferon gamma receptor 2  CD244 CD244 molecule, natural killer cell  ITGAL integrin, alpha L receptor 2B4  CD247 CD247 molecule  ITGB2 integrin, beta 2 (complement component  CD48 CD48 molecule 3 receptor 3 and 4 subunit)  CSF2 colony stimulating factor 2 (granulocyte-  KIR2DL1 killer cell immunoglobulin-like receptor, macrophage) two domains, long cytoplasmic tail, 1  FAS Fas cell surface death receptor  KIR2DL2 killer cell immunoglobulin-like receptor,  FASLG (TNF superfamily, member 6) two domains, long cytoplasmic tail, 2  FCER1G Fc fragment of IgE, high affinity I,  KIR2DL3 killer cell immunoglobulin-like receptor, receptor for; gamma polypeptide two domains, long cytoplasmic tail, 3  FCGR3A Fc fragment of IgG, low affinity IIIa,  KIR2DL4 killer cell immunoglobulin-like receptor, receptor (CD16a) two domains, long cytoplasmic tail, 4  FCGR3B Fc fragment of IgG, low affinity IIIb,  KIR2DL5A killer cell immunoglobulin-like receptor (CD16b) receptor, two domains, long cytoplasmic tail, 5A  FYN FYN proto-oncogene, Src family tyrosine  KIR2DS1 killer cell immunoglobulin-like receptor, kinase two domains, short cytoplasmic tail, 1  GRB2 growth factor receptor-bound 2  KIR2DS2 killer cell immunoglobulin-like receptor,  GZMB granzyme B two domains, short cytoplasmic tail, 2  HCST hematopoietic cell signal transducer  KIR2DS3 killer cell immunoglobulin-like receptor,  HLA-A major histocompatibility complex, class I, two domains, short cytoplasmic tail, 3 A  KIR2DS4 killer cell immunoglobulin-like receptor,  HLA-B major histocompatibility complex, class I, two domains, short cytoplasmic tail, 4 B  KIR2DS5 killer cell immunoglobulin-like receptor,  HLA-C major histocompatibility complex, class I, two domains, short cytoplasmic tail, 5 C  KIR3DL1 killer cell immunoglobulin-like receptor,  HLA-E major histocompatibility complex, class I, three domains, long cytoplasmic tail, 1 E  KIR3DL2 killer cell immunoglobulin-like receptor,  HLA-G major histocompatibility complex, class I, three domains, long cytoplasmic tail, 2 G  KLRC1 killer cell lectin-like receptor subfamily C,  ICAM1 intercellular adhesion molecule 1 member 1  ICAM2 intercellular adhesion molecule 2  KLRD1 killer cell lectin-like receptor subfamily D,  IFNAR1 interferon (alpha, beta and omega) member 1 LAT linker for activation of T cells receptor 1  LCK proto-oncogene, Src family tyrosine  IFNAR2 interferon (alpha, beta and omega) kinase receptor 2  LCP2 lymphocyte cytosolic protein 2

 MAPK1 mitogen-activated protein kinase 1  RAC1 ras-related C3 botulinum toxin substrate 1  MAPK3 mitogen-activated protein kinase 3  RAC2 ras-related C3 botulinum toxin substrate 2  MICA MHC class I polypeptide-related sequence  RAC3 ras-related C3 botulinum toxin substrate 3 A  RAF1 Raf-1 proto-oncogene, serine/threonine  MICB MHC class I polypeptide-related sequence kinase B  SH2D1A SH2 domain containing 1A  NCR1 natural cytotoxicity triggering receptor 1  SH3BP2 SH3-domain binding protein 2  SHC1 SHC (Src homology 2 domain containing)  NCR2 natural cytotoxicity triggering receptor 2 transforming protein 1  NCR3 natural cytotoxicity triggering receptor 3  SHC2 SHC (Src homology 2 domain containing)  NFATC1 nuclear factor of activated T-cells, transforming protein 2 cytoplasmic, calcineurin- dependent 1  SYK spleen tyrosine kinase  NFATC2 nuclear factor of activated T-cells,  TNF tumor necrosis factor cytoplasmic, calcineurin- dependent 2  TNFRSF10B tumor necrosis factor receptor  PAK1 p21 protein (Cdc42/Rac)-activated kinase superfamily, member 10b 1  TNFSF10 tumor necrosis factor (ligand)  PIK3CA phosphatidylinositol-4,5-bisphosphate superfamily, member 10 3-kinase, catalytic subunit alpha  TYROBP TYRO protein tyrosine kinase binding  PIK3CB phosphatidylinositol-4,5-bisphosphate 3- protein kinase, catalytic subunit beta  ULBP1 UL16 binding protein 1  PIK3CD phosphatidylinositol-4,5-bisphosphate  ULBP2 UL16 binding protein 2 3-kinase, catalytic subunit delta  ULBP3 UL16 binding protein 3  PIK3R1 phosphoinositide-3-kinase, regulatory  VAV1 vav 1 guanine nucleotide exchange factor subunit 1 (alpha)  VAV2 vav 2 guanine nucleotide exchange factor  PIK3R2 phosphoinositide-3-kinase, regulatory  VAV3 vav 3 guanine nucleotide exchange factor subunit 2 (beta)  ZAP70 zeta-chain (TCR) associated protein  PIK3R3 phosphoinositide-3-kinase, regulatory kinase 70kDa subunit 3 (gamma)  ACTB Actin, beta  PLCG1 phospholipase C, gamma 1  B2M Beta-2-microglobulin  PLCG2 phospholipase C, gamma 2  GAPDH Glyceraldehyde-3-phosphate (phosphatidylinositol-specific) dehydrogenase  PRF1 perforin 1 (pore forming protein)  GUSB Glucuronidase, beta  PTK2B protein Tyrosine Kinase 2 Beta  HPRT1 Hypoxanthine phosphoribosyltransferase  PTPN11 protein tyrosine phosphatase, non- 1 receptor type 11  PGK1 Phosphoglycerate kinase 1  PTPN6 protein tyrosine phosphatase, non-  PPIA Peptidylprolyl isomerase A receptor type 6  RPL13A Ribosomal protein L13a

Usage This product is offered by Biomol for research purposes only. Not for diagnostic purposes or human use. It may not be resold or used to manufacture commercial products without written approval of Biomol GmbH.